Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation

被引:34
|
作者
Rayya, F. [1 ]
Harms, J. [1 ]
Martin, A. P. [1 ]
Bartels, M. [1 ]
Hauss, J. [1 ]
Fangmann, J. [1 ]
机构
[1] Univ Leipzig, Clin Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany
关键词
D O I
10.1016/j.transproceed.2008.03.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A safe and effective preservation solution is a precondition for successful orthotopic liver transplantation (OLT). This study compared University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions in OLT. Patients and Methods. We retrospectively reviewed the medical records of 137 primary cadaveric. OLT performed between January 2003 and December 2006 at our institution. Sixty-eight grafts were harvested using UW and 69 using HTK. Recipients were managed similarly in regard to operative techniques and immunosuppression. We collected donor data including serum transaminases, serum sodium, ICU stay and assessed macroscopic liver quality. Recipient serum transaminases were collected on postoperative days 1, 7, 14, and 30. We compared biliary and vascular complications, as well as patient and graft survivals. Results. Mean serum bilirubin levels were slightly higher in the HTK group at 1,7,14, and 30 days after transplantation, whereas transaminases were higher in the UW group. Primary nonfunction occurred in 1 patient in each group. Retransplantation was performed in 5 patients in the UW and in 9 patients in the HTK group. Biliary complication rates were similar in the UW and HTK groups (22% and 17%, respectively). Six arterial complications occurred in the HTK (8.7%) and 2 in the UW group (2.9%; P < .05). Mean follow-up was 25 months. Graft survival at 1, 12, and 36 months was 90%, 78%, and 75% versus 90%, 71%, and 71% in the UW versus HTK groups, respectively. One-, 12-, and 36-month patient survival rates were 93%, 78%, and 75% versus 93%, 78%, and 78% in the UW versus HTK groups, respectively. Conclusions. There were no significant differences in graft and patient survivals between the 2 groups. Whereas the biliary complication rates were comparable in both groups, the arterial complications were clearly higher in the UW group (8.7% vs 2.9%; P < .05%). UW and HTK solutions seemed to be equally safe and effective in the preservation of liver grafts. The high incidence of arterial complications in the UW group requires further prospective studies.
引用
收藏
页码:891 / 894
页数:4
相关论文
共 50 条
  • [31] Tolerance of the porcine pancreas to warm and cold ischemia: Comparison between University of Wisconsin and histidine-tryptophan-ketoglutarate solution
    Troisi, R
    Meester, D
    Regaert, B
    van den Broecke, C
    Cuvelier, C
    Hesse, UJ
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (03) : 820 - 822
  • [32] Combined Flush With Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solutions in Liver Transplantation: Preliminary Results
    Leon Diaz, F. J.
    Fernandez Aguilar, J. L.
    Nicolas de Cabo, S.
    Perez Reyes, M.
    Sanchez Perez, B.
    Montiel Casado, C.
    Perez Daga, J. A.
    Aranda Narvaez, J. M.
    Suarez Munoz, M. A.
    Arenas Gonzalez, F.
    Florez Rias, M. M.
    Pelaez Angulo, J. L.
    Santoyo Santoyo, J.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 539 - 542
  • [33] Comparative analysis of clinical efficacy and cost between University of Wisconsin solution and histidine-tryptophan-ketoglutarate
    Bellamy, Chris A.
    Nicely, Bruce
    Mattice, Burton J.
    Teaster, Rob
    PROGRESS IN TRANSPLANTATION, 2008, 18 (03) : 166 - 171
  • [34] Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation
    Chan, SC
    Liu, CL
    Lo, CM
    Fan, ST
    LIVER TRANSPLANTATION, 2004, 10 (11) : 1415 - 1421
  • [35] Flow and pressure during liver preservation under ex situ and in situ perfusion with university of wisconsin solution and histidine-tryptophan-ketoglutarate solution
    Moench, C.
    Heimann, A.
    Foltys, D.
    Schneider, B.
    Minouchehr, S.
    Schwandt, E.
    Knaak, M.
    Kempski, O.
    Otto, G.
    EUROPEAN SURGICAL RESEARCH, 2007, 39 (03) : 175 - 181
  • [36] Histidine-Tryptophan-Ketoglutarate Solution Is Associated with Lower Risk of Postreperfusion Syndrome Compared with University of Wisconsin Solution in Orthotopic Liver Transplantation with Donations After Cardiac Death
    Sun, Fei
    Li, Zhiwei
    Zhang, Qiyi
    Wang, Yan
    Yan, Sheng
    Wang, Weilin
    Zheng, Shusen
    TRANSPLANTATION, 2016, 100 : S129 - S129
  • [37] Safety and feasibility of modified histidine-tryptophan-ketoglutarate solution for liver preservation prior transplantation
    Kaiser, Gernot M.
    Heuer, Matthias
    Reinhardt, Renate
    Kneiseler, Guntje
    Baba, Hideo
    Wuerzinger, Phillip
    Rauen, Ursula
    Paul, Andreas
    Minor, Thomas
    TRANSPLANTATION, 2013, 96 (10) : S257 - S257
  • [38] COMPARISON OF HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) SOLUTION AND INDIGENOUS NACL BASED SOLUTION IN LIVE RENAL TRANSPLANTATION
    Vijayakumar, Mohankumar
    Balaji, Sudharshan
    Singh, Abhishek
    Ganpule, Arvind
    Sabnis, Ravindra
    Desai, Mahesh
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1038 - E1038
  • [39] PROLONGED RAT KIDNEY PRESERVATION WITH ET-KYOTO SOLUTION: COMPARISON WITH HISTIDINE-TRYPTOPHAN-KETOGLUTARATE AND UNIVERSITY OF WISCONSIN SOLUTIONS
    Zhao, Xiangdong
    Fujinaga, Takuji
    Li, Ying
    Tsuruyama, Tatsuaki
    Bando, Toru
    Wada, Hiromi
    Date, Hiroshi
    TRANSPLANT INTERNATIONAL, 2011, 24 : 196 - 197
  • [40] Histidine-Tryptophan-Ketoglutarate Solution for Donor Heart Preservation Is Safe for Transplantation
    Mokbel, Majd
    Zamani, Haniyeh
    Lei, Ienglam
    Chen, Y. Eugene
    Romano, Matthew A.
    Aaronson, Keith D.
    Haft, Jonathan W.
    Pagani, Francis D.
    Tang, Paul C.
    ANNALS OF THORACIC SURGERY, 2020, 109 (03): : 763 - 770